206 related articles for article (PubMed ID: 31427601)
1. High-throughput screen reveals sRNAs regulating crRNA biogenesis by targeting CRISPR leader to repress Rho termination.
Lin P; Pu Q; Wu Q; Zhou C; Wang B; Schettler J; Wang Z; Qin S; Gao P; Li R; Li G; Cheng Z; Lan L; Jiang J; Wu M
Nat Commun; 2019 Aug; 10(1):3728. PubMed ID: 31427601
[TBL] [Abstract][Full Text] [Related]
2. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
[TBL] [Abstract][Full Text] [Related]
3. Transcription termination and antitermination of bacterial CRISPR arrays.
Stringer AM; Baniulyte G; Lasek-Nesselquist E; Seed KD; Wade JT
Elife; 2020 Oct; 9():. PubMed ID: 33124980
[TBL] [Abstract][Full Text] [Related]
4. Analysis of direct repeats and spacers of CRISPR/Cas systems type I-F in Brazilian clinical strains of Pseudomonas aeruginosa.
Luz ACO; da Silva JMA; Rezende AM; de Barros MPS; Leal-Balbino TC
Mol Genet Genomics; 2019 Oct; 294(5):1095-1105. PubMed ID: 31098740
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-dCas13a system for programmable small RNAs and polycistronic mRNA repression in bacteria.
Ko SC; Woo HM
Nucleic Acids Res; 2024 Jan; 52(1):492-506. PubMed ID: 38015471
[TBL] [Abstract][Full Text] [Related]
6. Bacterial alginate regulators and phage homologs repress CRISPR-Cas immunity.
Borges AL; Castro B; Govindarajan S; Solvik T; Escalante V; Bondy-Denomy J
Nat Microbiol; 2020 May; 5(5):679-687. PubMed ID: 32203410
[TBL] [Abstract][Full Text] [Related]
7. Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system.
Høyland-Kroghsbo NM; Paczkowski J; Mukherjee S; Broniewski J; Westra E; Bondy-Denomy J; Bassler BL
Proc Natl Acad Sci U S A; 2017 Jan; 114(1):131-135. PubMed ID: 27849583
[TBL] [Abstract][Full Text] [Related]
8. Toward a Comprehensive Analysis of Posttranscriptional Regulatory Networks: a New Tool for the Identification of Small RNA Regulators of Specific mRNAs.
Han K; Lory S
mBio; 2021 Feb; 12(1):. PubMed ID: 33622723
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Transcription Termination of Small RNAs and by Small RNAs: Molecular Mechanisms and Biological Functions.
Chen J; Morita T; Gottesman S
Front Cell Infect Microbiol; 2019; 9():201. PubMed ID: 31249814
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
11. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
[TBL] [Abstract][Full Text] [Related]
12. Repurposing type I-F CRISPR-Cas system as a transcriptional activation tool in human cells.
Chen Y; Liu J; Zhi S; Zheng Q; Ma W; Huang J; Liu Y; Liu D; Liang P; Songyang Z
Nat Commun; 2020 Jun; 11(1):3136. PubMed ID: 32561716
[TBL] [Abstract][Full Text] [Related]
13. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
[TBL] [Abstract][Full Text] [Related]
14. The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system.
Semenova E; Kuznedelov K; Datsenko KA; Boudry PM; Savitskaya EE; Medvedeva S; Beloglazova N; Logacheva M; Yakunin AF; Severinov K
Nucleic Acids Res; 2015 Jul; 43(12):6049-61. PubMed ID: 26013814
[TBL] [Abstract][Full Text] [Related]
15. Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription.
Stanley SY; Borges AL; Chen KH; Swaney DL; Krogan NJ; Bondy-Denomy J; Davidson AR
Cell; 2019 Sep; 178(6):1452-1464.e13. PubMed ID: 31474367
[TBL] [Abstract][Full Text] [Related]
16. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
[TBL] [Abstract][Full Text] [Related]
17. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
[TBL] [Abstract][Full Text] [Related]
18. A Type I-F Anti-CRISPR Protein Inhibits the CRISPR-Cas Surveillance Complex by ADP-Ribosylation.
Niu Y; Yang L; Gao T; Dong C; Zhang B; Yin P; Hopp AK; Li D; Gan R; Wang H; Liu X; Cao X; Xie Y; Meng X; Deng H; Zhang X; Ren J; Hottiger MO; Chen Z; Zhang Y; Liu X; Feng Y
Mol Cell; 2020 Nov; 80(3):512-524.e5. PubMed ID: 33049228
[TBL] [Abstract][Full Text] [Related]
19. Temperature, by Controlling Growth Rate, Regulates CRISPR-Cas Activity in Pseudomonas aeruginosa.
Høyland-Kroghsbo NM; Muñoz KA; Bassler BL
mBio; 2018 Nov; 9(6):. PubMed ID: 30425154
[TBL] [Abstract][Full Text] [Related]
20. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
Xiao Y; Ng S; Nam KH; Ke A
Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
